IMPROVED: Complex Peri-operative Intervention in Older Patients With Cancer

Sponsor
Assistance Publique - Hôpitaux de Paris (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04709055
Collaborator
Société Francophone d'Onco-Gériatrie (Other), Federation of Research in Surgery (FRENCH) (Other), PACAN - Plateforme de Recherche Clinique Patients Agés et Cancer (Other)
630
1
2
45
14

Study Details

Study Description

Brief Summary

Incidence of digestive cancers increase and half of new cases will be people of 75 years or more in 2050. Surgery is one of the main treatment's strategy but post-operative morbi-mortality increases with age. Pre-operative Geriatric Assessment enable to identify frail or vulnerable patients at risk of post-operative complications.

The coordinating team postulate that a geriatric and surgical co-management with a combination of several targeted geriatric interventions with usual post-operative care could improve the post-operative care and decrease the risk of morbi-mortality in older patients with digestive cancers.

Condition or Disease Intervention/Treatment Phase
  • Other: Co-management
  • Other: Usual care
N/A

Detailed Description

Multicenter Randomized Clinical Trial in 2 parallel-groups with masked adjudication of main endpoint

Study Design

Study Type:
Interventional
Anticipated Enrollment :
630 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Implementation of coMplex PeRi-OperatiVe intervEntion in olDer Patients With Cancer : a Multicenter Randomized Controlled Trial
Anticipated Study Start Date :
Jan 14, 2021
Anticipated Primary Completion Date :
Aug 14, 2024
Anticipated Study Completion Date :
Oct 14, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Co-management arm (geriatric and surgical)

Other: Co-management
Personalized and intensive geriatric peri-operative care

Active Comparator: Usual care

Other: Usual care
Pre-operative and post-operative geriatric care as per usual practice

Outcome Measures

Primary Outcome Measures

  1. Percentage of patients with postoperative complications of grade II or higher in the Clavien-Dindo [at 30 days after surgery]

Secondary Outcome Measures

  1. Percentage of patients with postoperative complications of each grade in the Clavien-Dindo [at Day 14 and Day 30]

  2. Percentage of patients with each complication among a prespecified list of complication [at Day 14 and Day 30]

  3. Social Status [at Day 14 and Day 30 after surgery]

  4. Activities of Daily Living Scale [at Day 14 and Day 30 after surgery]

  5. Instrumental Activities of Daily Living Scale [at Day 14 and Day 30 after surgery]

  6. Mini-Geriatric Depressive Scale [at Day 14 and Day 30 after surgery]

  7. Mini cognitive scale [at Day 14 and Day 30 after surgery]

  8. Updated Charlson Comorbidity Index [at Day 14 and Day 30 after surgery]

  9. Mini Nutritional Assessment-Short Form [at Day 14 and Day 30 after surgery]

  10. Body mass index [at Day 14 and Day 30 after surgery]

  11. Timed Up and Go [at Day 14 and Day 30 after surgery]

  12. Gait speed [at Day 14 and Day 30 after surgery]

  13. Percentage of patients with cancelled surgeries [at Day 0 to Day 8]

  14. Percentage of patients with postponed surgeries [at Day 0 to Day 8]

  15. Percentage of patients with complete intervention in the experimental arm [at Day 0 to Day 8]

  16. Time of onset of each post-operative complication [at Day 14, Day 30 and Day 90 after surgery]

  17. Percentage of patients transfered to geriatric unit, intensive care unit, rehabilitation unit or other departement. [at Day 14, Day 30 and Day 90 after surgery]

  18. Length of stay to geriatric unit, intensive care unit, rehabilitation unit or other departement. [at Day 14, Day 30 and Day 90 after surgery]

  19. Quality of life (European Organisation for Research and Treatment of Cancer - Quality of life - C30) [at Day 30 and Day 90 after surgery]

  20. Quality of life (European Organisation for Research and Treatment of Cancer - Quality of life - ELD14) [at Day 30 and Day 90 after surgery]

  21. Overall survival [at Day 30 and Day 90 after surgery]

  22. Length of hospitalizations [at Day 14 after surgery]

  23. Percentage of patients returned at home or institutionalization [at Day 14, Day 30 and Day 90 after surgery]

  24. Autonomy (Activities of Daily Living scale) [at Day 14 , Day 30 and Day 90 after surgery]

  25. Patient and professionals experience (ancillary study using semi-directive interviews) [at Day 30 after surgery]

Eligibility Criteria

Criteria

Ages Eligible for Study:
75 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Aged 75 years or more

  • Gastric, colo-rectal, pancreatic cancer or hepatic metastasis needed a surgical treatment

  • Health Insurance

  • At risk of post-operative complication through Surgical Risk Calculator (>25%) or surgeon judgment.

  • Written consent

Exclusion Criteria:
  • Surgery in emergency

Contacts and Locations

Locations

Site City State Country Postal Code
1 Assistance Publique Hôpitaux de Paris - Hôpital européen Georges-Pompidou Paris France 75015

Sponsors and Collaborators

  • Assistance Publique - Hôpitaux de Paris
  • Société Francophone d'Onco-Gériatrie
  • Federation of Research in Surgery (FRENCH)
  • PACAN - Plateforme de Recherche Clinique Patients Agés et Cancer

Investigators

  • Principal Investigator: Elena PAILLAUD LAURENT PUIG, MD, PhD, Assistance Publique Hôpitaux de Paris (AP-HP)

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT04709055
Other Study ID Numbers:
  • APHP180675
  • 2020-A01354-35
First Posted:
Jan 14, 2021
Last Update Posted:
Jan 19, 2021
Last Verified:
Sep 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Assistance Publique - Hôpitaux de Paris
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 19, 2021